Electronic healthcare records (EHR)
VAC4EU Postauthorisation Safety Study of BIMERVAX® Vaccine in Europe
Spain
EU PAS number:
EUPAS1000000321
First published:
02/07/2025
StudyPlanned
REACH study: Real-World Evidence study of OM-85 in Adults and Children in China, Italy, and Belgium
Belgium
China
Italy
EU PAS number:
EUPAS1000000316
First published:
27/06/2025
StudyPlanned
Postauthorisation Safety Study (PASS) of Avatrombopag and Haematological Malignancies in Patients With Primary Immune Thrombocytopaenia
Denmark
Sweden
EU PAS number:
EUPAS1000000315
First published:
18/12/2024
StudyPlanned
A Non-Interventional Post-Authorization Safety Study of Pfizer-BioNTech Bivalent COVID-19 Vaccine in the United States (US)
United States
EU PAS number:
EUPAS1000000314
First published:
31/01/2025
StudyDiscontinued
Post-marketing Study Assessing the Serious Cardiovascular Events Among Osteoporotic Patients Initiating Romosozumab in Japan Using the Medical Information Database Network (MID-NET) (20190206)
Japan
EU PAS number:
EUPAS1000000308
First published:
08/01/2025
StudyOngoing
Post-marketing observational surveillance study to evaluate pregnancy outcomes among women who receive Heplisav-B or Engerix-B (DV2-HBV-28)
United States
EU PAS number:
EUPAS1000000304
First published:
02/09/2024
StudyFinalised
Tarlatamab vs. Real-world Physicians’ Choice Therapies in Patients with Relapsed or Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment: Patient-level Indirect Treatment Comparison (ITC) of DeLLphi-301 vs. Flatiron Real-world Data (20240049)
United States
EU PAS number:
EUPAS1000000298
First published:
12/05/2025
StudyFinalised
Observational Cohort Study Evaluating Real-World ABRYSVO Vaccine Effectiveness and Impact Against Medically-Attended RSV-related and All-Cause Outcomes Among Infants Born to Individuals Vaccinated During Pregnancy
United States
EU PAS number:
EUPAS1000000295
First published:
09/01/2025
StudyPlanned
A Post-Authorization Safety Study of Atrial Fibrillation Following Respiratory Syncytial Virus Vaccine (ABRYSVOTM) Among Older Adults in the Veterans Affairs Health System (C3671037)
United States
EU PAS number:
EUPAS1000000290
First published:
03/06/2025
StudyOngoing
Chronic Kidney Disease Eligible for SGLT2 Inhibitors Through the Integration of Italian Administrative and Primary Care Data
Italy
EU PAS number:
EUPAS1000000269
First published:
17/07/2024
StudyFinalised